In conclusion, our study indicated that ADAM8 was an important biomarker for the prognosis of colon cancer and induced EMT to promote the invasion of colon cancer cells via activating TGF‐β/Smad2/3 signalling pathway. The gene discussed is SMAD2; the disease is malignant colon neoplasm.